Simin Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simin Xie has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Chengchen Hu
State Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences Fudan University Shanghai China
1 shared publication- Dama Faniriantsoa Henrio Marcellin
Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China
1 shared publication - Guoqiang Yin
College of Chemistry and Chemical Engineering
1 shared publication - Ismail Bilal Masokano
Center for Pulmonary Imaging Research, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC-2021, Cincinnati, OH 45229
1 shared publication - Jiefeng Zheng
College of Chemistry and Chemical Engineering, Zhongkai University of Agriculture and Engineering, Guangzhou 510220, China
1 shared publication Jing Cui
State Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Collaborative Innovation Center of Genetics and Development, School of Life Sciences Fudan University Shanghai China
1 shared publication
Latest Publications
Disruption of Ephb1 causes reduced hypothalamic CRH and TRH expression and obesity in mice
Objective: Ephrin type‐B receptor 1 (EphB1) is a receptor tyrosine kinase involved in axon guidance, synaptic plasticity, and tumorigenesis. However, the role of EphB1 in metabolic regulation and obesity remains poorly understood. This study aims to uncover the role of EphB1 in energy metabolism and provide insights into the underlying mechanisms by which EphB1 regulates obesity.Methods: Two Ephb1 mutations identified from a forward genetic screen for obesity‐related loci in mice were examined for their effects in gene expression, energy metabolism, and endocrine changes. The impacts of EphB1 on neuropeptide expression and signal transduction were evaluated in both hypothalamic tissues and primary cells. Potential downstream signals were modified in Ephb1 mutants to verify the interaction.Results: Ephb1 mutants develop obesity in adolescence and develop impaired glucose tolerance during adulthood. EphB1 deficiency caused lower body temperature, blunted cold‐induced thermogenesis, and decreased locomotor activity, but it did not alter food intake. EphB1 promotes cyclic AMP‐responsive element‐binding protein (CREB) phosphorylation via phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) signaling in a cell‐autonomous manner. EphB1 deficiency leads to reduced expression of corticotropin‐releasing hormone (CRH) and thyrotropin‐releasing hormone (TRH) in the brain. Intraventricular administration of either TRH or a CRH fragment suppressed obesity in Ephb1 mutants.Conclusions: EphB1 regulates hypothalamic CRH and TRH expression and promotes energy expenditure in mice.
Disruption of Ephb1 causes reduced hypothalamic CRH and TRH expression and obesity in mice
Objective: Ephrin type‐B receptor 1 (EphB1) is a receptor tyrosine kinase involved in axon guidance, synaptic plasticity, and tumorigenesis. However, the role of EphB1 in metabolic regulation and obesity remains poorly understood. This study aims to uncover the role of EphB1 in energy metabolism and provide insights into the underlying mechanisms by which EphB1 regulates obesity.Methods: Two Ephb1 mutations identified from a forward genetic screen for obesity‐related loci in mice were examined for their effects in gene expression, energy metabolism, and endocrine changes. The impacts of EphB1 on neuropeptide expression and signal transduction were evaluated in both hypothalamic tissues and primary cells. Potential downstream signals were modified in Ephb1 mutants to verify the interaction.Results: Ephb1 mutants develop obesity in adolescence and develop impaired glucose tolerance during adulthood. EphB1 deficiency caused lower body temperature, blunted cold‐induced thermogenesis, and decreased locomotor activity, but it did not alter food intake. EphB1 promotes cyclic AMP‐responsive element‐binding protein (CREB) phosphorylation via phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) signaling in a cell‐autonomous manner. EphB1 deficiency leads to reduced expression of corticotropin‐releasing hormone (CRH) and thyrotropin‐releasing hormone (TRH) in the brain. Intraventricular administration of either TRH or a CRH fragment suppressed obesity in Ephb1 mutants.Conclusions: EphB1 regulates hypothalamic CRH and TRH expression and promotes energy expenditure in mice.
- 25 May 2021
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 9 (25) , 8020-8028
Facile fabrication of eugenol-containing polysiloxane films with good optical properties and excellent thermal stabilityviaSi–H chemistry
Transparent and easily fabricated films were obtained through the coupling of eugenol, a bio-sourced feedstock, and poly(methylhydrosiloxane), via the Piers–Rubinsztajn reaction and Pt-catalysed hydrosilylation. The precursor reagents are readily available and economical, and the reaction process used was mild and easily undertaken. Additionally, poly(methylhydrosiloxane), having an abundant source of pendant Si–H groups, can be cross-linked with eugenol at multiple juncture points, and thus the eugenol content in these films ranges from 13.12 to 45.42 wt%. It was found that as the eugenol content increased, the thermal stability of the films also improved, with T10% and Rw at 700 °C ranging from 350.1 to 584.3 °C and 46.41 to 86.63%, respectively, which is higher than other analogous biomass-derived polysiloxanes. Crucially, the prepared films also exhibited suitable optical properties, with a >90% transmittance within the 430–1100 nm region and near 100% absorbance in the UV region (1.5) LED encapsulants and also in stacked multi-layer reflectors. In addition, to protect the encapsulated chips from moisture erosion, these films exhibit good water vapour barrier properties and water repellence.
- 25 May 2021
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 9 (25) , 8020-8028
Facile fabrication of eugenol-containing polysiloxane films with good optical properties and excellent thermal stabilityviaSi–H chemistry
Transparent and easily fabricated films were obtained through the coupling of eugenol, a bio-sourced feedstock, and poly(methylhydrosiloxane), via the Piers–Rubinsztajn reaction and Pt-catalysed hydrosilylation. The precursor reagents are readily available and economical, and the reaction process used was mild and easily undertaken. Additionally, poly(methylhydrosiloxane), having an abundant source of pendant Si–H groups, can be cross-linked with eugenol at multiple juncture points, and thus the eugenol content in these films ranges from 13.12 to 45.42 wt%. It was found that as the eugenol content increased, the thermal stability of the films also improved, with T10% and Rw at 700 °C ranging from 350.1 to 584.3 °C and 46.41 to 86.63%, respectively, which is higher than other analogous biomass-derived polysiloxanes. Crucially, the prepared films also exhibited suitable optical properties, with a >90% transmittance within the 430–1100 nm region and near 100% absorbance in the UV region (1.5) LED encapsulants and also in stacked multi-layer reflectors. In addition, to protect the encapsulated chips from moisture erosion, these films exhibit good water vapour barrier properties and water repellence.
- Open Access
- 22 September 2020
- Published by Springer Nature in Cancer Imaging
- Vol. 20 (1) , 1-11
The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges
Recently, radiomic texture quantification of tumors has received much attention from radiologists, scientists, and stakeholders because several results have shown the feasibility of using the technique to diagnose and manage oncological conditions. In patients with hepatocellular carcinoma, radiomics has been applied in all stages of tumor evaluation, including diagnosis and characterization of the genotypic behavior of the tumor, monitoring of treatment responses and prediction of various clinical endpoints. It is also useful in selecting suitable candidates for specific treatment strategies. However, the clinical validation of hepatocellular carcinoma radiomics is limited by challenges in imaging protocol and data acquisition parameters, challenges in segmentation techniques, dimensionality reduction, and modeling methods. Identification of the best segmentation and optimal modeling methods, as well as texture features most stable to imaging protocol variability would go a long way in harmonizing HCC radiomics for personalized patient care. This article reviews the process of HCC radiomics, its clinical applications, associated challenges, and current optimization strategies.
- 22 September 2020
- Published by Springer Nature in Cancer Imaging
- Vol. 20 (1) , 1-11
Open AccessThe application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges
Recently, radiomic texture quantification of tumors has received much attention from radiologists, scientists, and stakeholders because several results have shown the feasibility of using the technique to diagnose and manage oncological conditions. In patients with hepatocellular carcinoma, radiomics has been applied in all stages of tumor evaluation, including diagnosis and characterization of the genotypic behavior of the tumor, monitoring of treatment responses and prediction of various clinical endpoints. It is also useful in selecting suitable candidates for specific treatment strategies. However, the clinical validation of hepatocellular carcinoma radiomics is limited by challenges in imaging protocol and data acquisition parameters, challenges in segmentation techniques, dimensionality reduction, and modeling methods. Identification of the best segmentation and optimal modeling methods, as well as texture features most stable to imaging protocol variability would go a long way in harmonizing HCC radiomics for personalized patient care. This article reviews the process of HCC radiomics, its clinical applications, associated challenges, and current optimization strategies.